← Back to Patent Explorer
US4983632A Expired / Lapsed US ⏱️ 0.0 years remaining

Use of gamma-hydroxybutyric acid salts for preparing pharmaceutical compositions for use in the treatment of alcoholism, and the compositions obtained

Assignee: Laboratorio Farmaceutico CT SRL
•
Filing: 1989-06-02
•
Granted: 1991-01-08
•
Expires: 2009-06-02
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract The use of gamma-hydroxybutyric acid salts for preparing pharmaceutical compositions useful for the release form ethyl alcohol consumption and the compostions obtained.

Inventors

  • 👤 Gian Luigi Gessa
  • 👤 Fabio Fadda
  • 👤 Chiara Mormile di Campochiaro

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-09 16:04
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/185; A61K31/19; A61P; A61P25/00; A61P25/30; A61P25/32

Claims Analysis

Total Claims: 12
Claim 1
Independent Claim 32 words
A method of treating ethyl alcohol dependency in a patient, which comprises: administering to said patient an effective amount of a pharmaceutically acceptable salt of gamma-hydroxy butyric acid for treating said dependency.
Claim 2
Independent Claim 32 words
A method of treating ethyl alcohol dependency in a patient, which comprises: administering to said patient an effective amount of a pharmaceutically acceptable salt of gamma-hydroxy butyric acid for treating said dependency.
Claim 3
Dependent Claim 23 words
The method of claim 1, wherein said pharmaceutically acceptable salt of gamma-hydroxy butyric acid is the sodium, potassium, calcium or magnesium salt thereof.
Claim 4
Dependent Claim 19 words
The method of claim 1, wherein said pharmaceutically acceptable salt of gamma-hydroxy butyric acid is the sodium salt thereof.
Claim 5
Dependent Claim 27 words
The method of claim 1, wherein the effective amount of the pharmaceutically acceptable salt of gamma-hydroxy butyric acid for treating said dependency is administered once a day.
Claim 6
Dependent Claim 31 words
The method of claim 1, wherein the effective amount of said pharmaceutically acceptable salt which is administered for treating said dependency is from 0.025 to 0.10 g/kg of the patient's weight.
Claim 7
Dependent Claim 27 words
The method of claim 4, wherein the effective amount of said pharmaceutically acceptable salt which is administered is from 0.025 to 0.10 g/kg of the patient's weight.
Claim 8
Dependent Claim 22 words
The method of claim 6, wherein said pharmaceutically acceptable salt is the sodium, potassium, calcium or magnesium salt of gamma-hydroxy butyric acid.
Claim 9
Dependent Claim 18 words
The method of claim 6, wherein said pharmaceutically acceptable salt is the sodium salt of gamma-hydroxy butyric acid.
Claim 10
Independent Claim 74 words
A method of treating ethyl alcohol dependency in a patient, which comprises: administering to said patient once a day from 0.025 to 0.10 g/kg of the patient's weight, of a pharmaceutically acceptable salt of gamma-hydroxy butyric acid, which is selected from the group consisting of: the sodium salt of gamma-hydroxy butyric acid, the potassium salt of gamma-hydroxy butyric acid, the calcium salt of gamma-hydroxy butyric acid, and the magnesium salt of gamma-hydroxy butyric acid.
Claim 11
Independent Claim 74 words
A method of treating ethyl alcohol dependency in a patient, which comprises: administering to said patient once a day from 0.025 to 0.10 g/kg of the patient's weight, of a pharmaceutically acceptable salt of gamma-hydroxy butyric acid, which is selected from the group consisting of: the sodium salt of gamma-hydroxy butyric acid, the potassium salt of gamma-hydroxy butyric acid, the calcium salt of gamma-hydroxy butyric acid, and the magnesium salt of gamma-hydroxy butyric acid.
Claim 12
Dependent Claim 19 words
The method of claim 9, wherein said pharmaceutically acceptable salt of gamma-hydroxy butyric acid is the sodium salt thereof.

References Cited (Backward Citations)

EP0044801A1 Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1994-01-07 1994-07-09 1995-01-08 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1998-01-07 1998-07-09 1999-01-08 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2002-01-07 2002-07-09 2003-01-08 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag